Following positive trial results, retatrutide, a novel peptide therapy for managing adult-onset hyperglycemia , has obtained regulatory approval from UK’s Healthcare and Healthcare Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/